EyeGene Inc Capital Reinvestment Ratio

Latest as of September 2023: 8.77x

EyeGene Inc capital reinvestment ratio. EyeGene Inc (185490) has a Capital Reinvestment Ratio of 8.77x as of September 2023, meaning it reinvests 9% of its operating cash flow (₩541.79 Million) in capital expenditures (₩4.75 Billion). Check EyeGene Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

8.77x

Capex / Operating Cash Flow

Operating Cash Flow

₩541.79 Million

KRW

Capital Expenditures

₩4.75 Billion

KRW

Data as of

Sep 2023

Most recent filing

EyeGene Inc Capital Reinvestment Ratio by Year (None–None)

EyeGene Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see cash efficiency ratio of EyeGene Inc.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow